Key for crossing the BBB with nanoparticles: the rational design

Beilstein J Nanotechnol. 2020 Jun 4:11:866-883. doi: 10.3762/bjnano.11.72. eCollection 2020.

Abstract

Central nervous system diseases are a heavy burden on society and health care systems. Hence, the delivery of drugs to the brain has gained more and more interest. The brain is protected by the blood-brain barrier (BBB), a selective barrier formed by the endothelial cells of the cerebral microvessels, which at the same time acts as a bottleneck for drug delivery by preventing the vast majority of drugs to reach the brain. To overcome this obstacle, drugs can be loaded inside nanoparticles that can carry the drug through the BBB. However, not all particles are able to cross the BBB and a multitude of factors needs to be taken into account when developing a carrier system for this purpose. Depending on the chosen pathway to cross the BBB, nanoparticle material, size and surface properties such as functionalization and charge should be tailored to fit the specific route of BBB crossing.

Keywords: blood–brain barrier (BBB); drug delivery; gold nanoparticles (AuNPs); liposomes; nanomedicine; polymeric nanoparticles; solid lipid nanoparticles; superparamagnetic iron oxide nanoparticles (SPIONs).

Publication types

  • Review

Grants and funding

This review has been written as part of the NANOSTEM project, a Marie Skłodowska-Curie Innovative Training Network (ITN). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 764958.